Micro-LiNiCoMnO2 (MNCM), a cathode material with highest market share, has increasing demand with the growth of lithium battery industry. However, whether MNCM exposure brings adverse effects to workers remains unclear. This study aimed to explore the association between MNCM exposure with systemic inflammation and cardiac function. A cross-sectional study of 347 workers was undertaken from the MNCM production industry in Guangdong province, China in 2020. Metals in urine were measured using ICP-MS. The associations between metals, systemic inflammation, and cardiac function were appraised using a linear or logistic regression model. Bayesian kernel machine regression (BKMR) and generalized weighted quantile sum (gWQS) models were used to explore mixed metal exposures. The analysis of interaction and mediation was adopted to assess the role of inflammation in the relation between urinary metals and cardiac function. We observed that the levels of lithium (Li) and cobalt (Co) were positively associated with systemic inflammation and heart rate. The amount of Co contributed the highest weight on the increased systemic immune-inflammation index (SII) (59.8%), the system inflammation response index (SIRI) (44.3%), and heart rate (65.0%). Based on the mediation analysis, we estimated that SII mediated 32.3% and 20.9% of the associations between Li and Co with heart rate, and SIRI mediated 44.6% and 22.2% of the associations between Li and Co with heart rate, respectively. This study demonstrated for the first time that MNCM exposure increased the risk of workers' systemic inflammation and elevated heart rate, which were contributed by the excessive Li and Co exposure. Additionally, it indicates that systemic inflammation was a major mediator of the associations of Li and Co with cardiac function in MNCM production workers.
1 December 2021 in Journal of Trace Elements in Medicine and Biology
Aristolochic Acid I (AAI) is widely present in traditional Chinese medicines derived from the Aristolochia genus and is known to cause significant damage to renal tubular epithelial cells. Genome-wide screening has proven to be a powerful tool in identifying critical genes associated with the toxicity of exogenous substances. To identify undiscovered key genes involved in AAI-induced renal toxicity, a genome-wide CRISPR library screen was conducted in the human kidney-2 (HK-2) cell line. Among the altered sgRNAs, a significant enrichment of those targeting the E2F transcription factor 1 (E2F1) gene was observed in surviving HK-2 cells in the AAI-treated group. Interestingly, the role of E2F1 had not been previously explored in studies of AAI nephrotoxicity. Further investigations revealed that E2F1 promotes apoptosis by activating the p53 signaling pathway and upregulating pro-apoptotic genes, such as BAK and BAX. Additionally, using the high-throughput experiment- and reference-guided database of traditional Chinese medicine (HERB), cannabidiol (CBD) was identified as an inhibitor of E2F1 by suppressing the activity of NF-κB pathway. In vitro and in vivo models confirmed that CBD inhibits AAI-induced upregulation of E2F1, thereby suppressing p53-mediated apoptosis. In conclusion, this study highlights the crucial role of E2F1 in AAI-induced renal cell apoptosis and identifies CBD as a novel therapeutic candidate for mitigating AAI nephrotoxicity.
23 July 2025 in Ecotoxicology and Environmental Safety
The Lithium nickel manganese cobalt oxide (NCM) is a representative new energy material widely used in industry and daily life, but the systemic health influence of exposure to NCM remained largely unknown. This study aimed to reveal the impacts of NCM exposure on biological age acceleration (BAA) and metabolic alteration, as well as the mediating roles of metabolites. NCM exposure was assessed through three methods: external exposure, biomarker of exposure to NCM mixture (Li, Ni, Co, and Mn), with a particular focus on Li exposure. BAA was calculated using the Klemera and Doubal methods, and untargeted metabolomics was conducted among a representative sample of participants (n = 100). High NCM external exposure showed higher BAA than those with low exposure (median BAA: 0.11 vs. -0.32 years), and increased dose-response relationships between NCM exposure biomarker and BAA were observed using two multi-exposure models. Li was the critical component to NCM exposure effects (weight = 0.793). The "meet-in-the-middle" approach identified twenty-eight metabolites associated with both external and biomarkers of exposure to NCM, Li exposure, and BAA (VIP ≥ 1 and FDR ≤ 0.05). Five key metabolites including TG(50:0)-TG(18:0/16:0/16:0), eicosadienoic acid, Gly-Glu, 2-Oxoarginine, and TG(55:1)-TG(16:0/18:1/21:0) mediated 18.10 %-89.40 % of NCM exposure-BAA association. Our findings provide epidemiological evidence on the hazardous NCM exposure and shed light on metabolic biomarkers for the identification and intervention of accelerated aging among populations.
Background: Lead (Pb) and cadmium (Cd) are common persistent environmental pollutants, may cause renal dysfunction following long-term exposure. This study investigated whether vascular endothelial growth factor a (VEGFA) gene polymorphisms modify the association between Pb and Cd exposure with renal dysfunction risk, given the key role of gene–environment interactions in kidney pathogenesis.Methods: A cross-sectional study of 408 workers was undertaken from a Pb-Cd smelter in Guangdong Province, China in 2023. Metals in blood and urine were measured using Inductively coupled plasma-Mass Spectrometry (ICP-MS). Additive, dominant and recessive genetic models were employed to analyze differences in genotype distribution of rs3025010, rs10434 and rs833061 between normal and renal dysfunction groups. Interaction analyses were conducted to examine the combined effects of blood lead (BPb) and urinary cadmium (UCd) exposure with these polymorphisms under different genetic models on renal dysfunction risk.Results: For rs833061 locus, BPb showed statistically significant differences in both the additive and recessive models (p < 0.05), while renal function exhibited differences in the additive and dominant models (p < 0.05). For rs3025010, BPb showed significant differences in the recessive model (p = 0.05), and renal function demonstrated differences in both additive and dominant models (p < 0.05). Multivariate regression analysis identified BPb and UCd as risk factors for renal dysfunction, with odds ratios ranging from 1.40 to 3.46 (p < 0.05). Interaction analyses revealed interactions between rs3025010 and Pb [BPb × rs3025010: OR (95%CI) = 0.69(0.49, 0.88)] in dominant model. The rs10434 locus interactions with Pb and Cd in both the additive [OR (95%CI) = 0.60 (0.31, 0.91)] and recessive models [OR (95%CI) = 0.51 (0.27, 0.85)].Conclusion: This study identified significant gene–environment interactions between VEGFA polymorphisms (rs3025010 and rs10434) and Pb-Cd co-exposure in renal dysfunction. These findings suggest that screening for these polymorphisms could identify high-risk populations for targeted prevention and control strategies.